CRISPR Antivirus Tool - Cas9 Inibits Hepatitis C In Human Cells
Researchers have adapted an antiviral enzyme from bacteria called Cas9 into an instrument for inhibiting hepatitis C virus in human cells. Cas9 is part of the CRISPR genetic defense system in bacteria, which scientists have been harnessing to edit DNA in animals, plants and even human cells. In this case, Emory researchers are using Cas9 to put a clamp on RNA, which hepatitis C virus uses for its genetic material, rather than change cells' DNA.
Although several effective drugs are now available to treat hepatitis C infection, the approach could have biotechnology applications.
"We can…